1 completed, 1 unknown. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Longidaza: new trials by email Literature Review of Longidaza trials Research Report on Longidaza
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age Longidaza, Metronidazole 500 mg - Bacterial Vaginosis | Phase 4 | Unknown | I.M. Sechenov First Moscow State Medical University | 100 | 2024-06-01 | 2025-04-09 |
| Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 Longidaza®, Placebo - Post-Acute COVID-19 Syndrome, Lung Disease With Polymyositis | Phase 3 | Completed | NPO Petrovax | 392 | 2022-04-08 | 2025-06-03 |
COVID-19 (1) · Disease (1) · Fibrosis (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Post-Acute COVID-19 Syndrome (1) · Vaginosis, Bacterial (1)
I.M. Sechenov First Moscow State Medical University (1) · NPO Petrovax (1)
Russia (2)
Kseniya Rossolovskaya (1) · Leonid Spivak, MD,Prof. (1) · Sergey Avdeev, DM (1)